Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Pieter C. Smits, Enrico Frigoli et al.|New England Journal of Medicine|2021Cited by 571
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial InfarctionFelix Böhm, Stefan James, Brynjólfur Mogensen et al.|New England Journal of Medicine|2024Cited by 99
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled TrialPieter C. Smits, Enrico Frigoli, Jan G.P. Tijssen et al.|Circulation|2021Cited by 77
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) StudyEnrico Frigoli, Marco Valgimigli, Pieter C. Smits et al.|American Heart Journal|2018Cited by 62
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding RiskPieter C. Smits, Marco Valgimigli, Enrico Frigoli et al.|Journal of the American College of Cardiology|2022Cited by 34